Literature DB >> 34320133

Indeterminate form of Chagas disease: historical, conceptual, clinical, and prognostic aspects.

Alejandro Marcel Hasslocher-Moreno1, Sergio Salles Xavier1, Roberto Magalhães Saraiva1, Andréa Silvestre de Sousa1,2.   

Abstract

Chagas disease (CD) remains a serious endemic disease in Latin America and a major public health problem. Because of globalization, the disease has spread to non-endemic areas in the northern hemisphere. In the chronic phase of the disease, most patients present with the indeterminate form (IF), characterized by positive serology for Trypanosoma cruzi, absence of clinical findings, and normal findings in electrocardiogram (ECG). IF was not recognized as a clinical entity until decades after the discovery of the disease, and only in the 1940-50s, it was categorized as a form of CD, and its conceptual definition was ratified in the 1980s. Children, adolescents, and young adults with the IF benefit from etiological treatment and tend to have less progression to heart disease in the long term than the untreated ones. IF patients have an essentially benign clinical condition, and their prognosis can be compared to that of healthy individuals with normal ECG findings. Currently, because of aging, patients with the IF have comorbidities that require attention in health services.

Entities:  

Mesh:

Year:  2021        PMID: 34320133     DOI: 10.1590/0037-8682-0254-2021

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

Review 1.  Longitudinal Speckle Tracking Strain Abnormalities in Chagas Disease: A Systematic Review and Meta-Analysis.

Authors:  Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Juliana Alexandra Hernández-Vargas; Jorge Largo; Taulant Muka; Luis E Echeverría
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

2.  Indeterminate Form of Chagas Disease: Some Immunological Insights.

Authors:  Daniel Mazza Matos; Carlos Eduardo Menezes Viana; Maria de Fátima Oliveira; José Ajax Nogueira Queiroz
Journal:  Rev Soc Bras Med Trop       Date:  2022-04-29       Impact factor: 2.141

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.